Antares Pharma Inc (ATRS) Return on Investment ROI from the first quarter of 2022 to first quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Antares Pharma Inc   (NASDAQ: ATRS)


Antares Pharma Inc's ROI from its first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Antares Pharma Inc's ROI in the first quarter of 2022?
Antares Pharma Inc achieved a return on average invested assets (ROI) of 23.3 % in its first quarter of 2022, this is above ATRS's average return on investment of -15.97%.
Antares Pharma Inc invested over the 12 months ending in its first quarter of 2022 $172 million

ROI decreased relative to the period ending Dec 31 2021, due to the decline in net income.

Within the Healthcare sector 52 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2021 from 265 to 357.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Investment Change TTM 42.34 % 44.46 % 48.1 % 36.8 % 31.96 %
Y / Y Net Income Change TTM -35.57 % -17.64 % 1249.78 % - -
Investment (TTM) in Millions 200 194 160 136 142
Return On Investment (TTM) 23.3 % 29.32 % 44.67 % 49.46 % 51.48 %
ATRS's Overall Ranking # 357 # 265 # 163 # 119 # 59
Seq. Investment Change TTM 9.22 % 8.5 % 11.39 % 7.83 % 10.84 %
Seq. Net Income Change TTM -13.21 % -28.78 % 0.61 % 3.6 % 10.94 %
Net Income (TTM) in Millions 40 46 65 65 62

ATRS Company Profile >> Back to ATRS Roi Comparisons >> See Annual ATRS Return On Investment



Return On Investment ATRS's Ranking
Within: No.
Industry # 12
Sector # 53
Overall # 357

Return On Investment Statistics
High Average Low
49.5 %
-15.97 %
-67.18 %
(Mar 31 2021)   (March 31, 2015)







Financial Statements
Antares Pharma Inc's I. Quarter Investments $ 200 Millions ATRS's Balance sheet
Antares Pharma Inc's I. Quarter Income $ -2 Millions Quarterly ATRS's Income Statement
ATRS's Income by Division See ATRS's Income by Division


ATRS Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 194 145 100 61 59
Y / Y Investment Growth 34.25 % 44.03 % 64.26 % 4.23 % 26.25 %
Net Income in Millions 46 56 -2 -7 -17
Y / Y Net Income Growth -17.64 % - - - -
Annual Return On Investment 23.86 % 38.89 % -2.02 % -10.67 % -28.57 %


Annual Roi Comment
In the fiscal year 2021 ROI decreased relative to the previous year to 23.86 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ATRS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ATRS's Competitors
Subscribers only: Roi for Antares Pharma Inc's Suppliers
Subscribers only: Return On Investment for ATRS's Customers

Other Ratios
ATRS's Roa ATRS's Inventory Turnover Ratio ATRS's Growth Rates ATRS's Dividend Statistics
ATRS's Profitability Ratios ATRS's Asset Turnover Ratio ATRS's Dividend Growth
ATRS's Roe ATRS's Valuation Ratios ATRS's Financial Strength Ratios ATRS's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Healthcare Sector ROI
Effector Therapeutics Inc   63.45 %
Iteos Therapeutics Inc   62.29 %
Vivos Therapeutics Inc   61.68 %
Biomx Inc  57.01 %
Ironwood Pharmaceuticals inc   50.50 %
Molecular Templates Inc   49.08 %
Embecta Corp   47.91 %
Quidelortho Corp  47.45 %
Journey Medical Corp  46.59 %
Siga Technologies Inc  46.30 %
Avid Bioservices Inc   43.65 %
Reflect Scientific Inc  43.50 %
Halozyme Therapeutics Inc   43.26 %
Uniqure N v   42.34 %
Idexx Laboratories Inc  41.85 %
Fulgent Genetics Inc   40.69 %
Integrated Biopharma Inc  39.72 %
Regeneron Pharmaceuticals Inc   38.88 %
Mettler toledo International Inc   35.82 %
Elite Pharmaceuticals Inc   35.24 %
Semler Scientific inc   34.94 %
Peak Bio Inc   34.37 %
Retractable Technologies Inc  32.83 %
Nrc Health  32.14 %
Co diagnostics Inc   32.06 %
Silo Pharma Inc  32.05 %
Exelixis Inc   30.33 %
Biocept Inc   29.66 %
Innoviva Inc   29.38 %
Clene Inc   28.78 %

Date modified: 2026-09-08T15:10:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.